title: Commentary on technical specifications and safety requirements of serum eye drops: Keeping a close eye on the content in cytokines.
authors: International Consultancy in Blood Components Quality/Safety, Audit/Inspection and DDR Strategies, London, UK. Electronic address: jseghatchian@btopenworld.com.
authors: Jerard
authors: J
authors: Seghatchian
authors: Department of Immunology and Transfusion Medicine, St. Olav's University Hospital, Trondheim, Norway.
authors: Aurora
authors: A
authors: Espinosa
authors: Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.
authors: Thierry
authors: T
authors: Burnouf
mesh_terms: D016207:Cytokines / Q000378:metabolism*; D006801:Humans; D009883:Ophthalmic Solutions / Q000627:therapeutic use*; D012015:Reference Standards; D012449:Safety; D044967:Serum / Q000378:metabolism*
chemical_list: D016207:Cytokines; D009883:Ophthalmic Solutions
keywords: Cytokines content of SED; Safety requirements of SED; Technical specification of SED